<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02565290</url>
  </required_header>
  <id_info>
    <org_study_id>UP4989/2014</org_study_id>
    <nct_id>NCT02565290</nct_id>
  </id_info>
  <brief_title>Effect of Mother's Supplementation Omega-3 in the Dynamics of Fetal Ductus Arteriosus: a Randomized Clinical Trial.</brief_title>
  <official_title>Effect of Mother's Supplementation Omega-3 in the Dynamics of Fetal Ductus Arteriosus: a Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Cardiologia do Rio Grande do Sul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Cardiologia do Rio Grande do Sul</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of anti-inflammatory substances on the dynamics of the fetal ductus arteriosus is
      well documented, but the anti-inflammatory property of polyunsaturated fatty acid omega-3
      about changing this dynamic is not established. This study evaluate the relationship between
      supplementation of omega-3 in the dynamics of the fetal ductus arteriosus in the third
      trimester. Women with gestational between 28 to 32 weeks will receive capsules of omega-3 or
      placebo, to be consumed daily for 3 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The omega-3 features similar the statins to be antioxidants and anti-inflammatory drugs and
      their derivatives have the function of slowing the neuro-inflammation, oxidative stress and
      apoptotic cell death anti-inflammatory properties. Also, they have antithrombotic effects,
      being related to prevent disease. Studies show that supplementation with omega-3 has a
      positive impact on several outcomes like cardiovascular disease, asthma, rheumatoid arthritis
      and Alzehimer. Objective: Evaluate the relationship between supplementation of omega-3 in the
      dynamics of the fetal ductus arteriosus in the third trimester. Methodology: randomized
      double blind clinical trial. Women with gestational age between 28 to 32 weeks, literate,
      over 18 years will be invited. Pregnant women with anti-inflammatory drugs, they have a
      higher intake of dietary polyphenols to 127mg / day or using drugs that may interfere with
      the absorption of omega-3 are excluded. The selected women will be randomized to receive
      capsules of omega-3 or placebo, to be consumed daily for 3 weeks. In the first interview, and
      after 3 weeks, they will respond the Questionnaire Food Frequency (QFF) to quantify
      polyphenols and omega 3 in their diet, weight and height will be measured and the examination
      of fetal echocardiography is performed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulsatility index of fetal ductus arteriosus</measure>
    <time_frame>28 to 32 weeks of pregnancy</time_frame>
    <description>The measure will be collected before and after 21 days of supplementation with omega 3 capsules</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic velocity of fetal ductus arteriosus</measure>
    <time_frame>28 to 32 weeks of pregnancy</time_frame>
    <description>The measure will be collected before and after 21 days of supplementation with omega 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory biomarkers (interleukins, prostaglandins, cyclooxygenase)</measure>
    <time_frame>28 to 32 weeks of pregnancy</time_frame>
    <description>Will be collected blood before and after 21 days of supplementation with omega 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of oxidative stress</measure>
    <time_frame>28 to 32 weeks of pregnancy</time_frame>
    <description>Will be collected blood before and after 21 days of supplementation with omega 3</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Omega-3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 capsules of omega 3 - 2 times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Soy oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 capsules of soy oil - 2 times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega 3</intervention_name>
    <description>Pregnant women should take 2 capsules of omega 3 (1g), 2 times a day, for 21 days.</description>
    <arm_group_label>Omega-3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soy Oil</intervention_name>
    <description>Pregnant women should take 2 capsules of placebo 3 - soy oil oil (1g), 2 times a day, for 21 days.</description>
    <arm_group_label>Soy oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Women between 28 - 32 weeks pregnancy who accept participate in the
        study.

        Exclusion Criteria: hypertensive , diabetic , who use anti-inflammatory drugs , HIV
        positive , do not take mate, black or green tea, had inflammation in the last 5 days,
        allergic to fish or soy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulo Zielinsky, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Instituto de Cardiologia do Rio Grande do Sul</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paulo Zielinsky, Doctor</last_name>
    <email>paulozie.voy@terra.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Camila Brum, Master</last_name>
    <email>andradebrum@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Paulo Zielinsky</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90620-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camila Brum, Master</last_name>
      <phone>(51) 32303600</phone>
      <email>andradebrum@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Izabele Vian, Master</last_name>
      <email>izabele.nutri@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Paulo Zielinsky, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camila Brum, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Izabele Vian, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antônio Piccoli, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Henrique Nicoloso, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Melissa Markoski, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Maria Zilio, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Zielinsky P, Piccoli AL Jr, Vian I, Zílio AM, Naujorks AA, Nicoloso LH, Barbisan CW, Busato S, Lopes M, Klein C. Maternal restriction of polyphenols and fetal ductal dynamics in normal pregnancy: an open clinical trial. Arq Bras Cardiol. 2013 Sep;101(3):217-25. doi: 10.5935/abc.20130166. Epub 2013 Aug 14. English, Portuguese.</citation>
    <PMID>23949325</PMID>
  </results_reference>
  <results_reference>
    <citation>Vian I, Zielinsky P, Zilio AM, Mello A, Lazzeri B, Oliveira A, Lampert KV, Piccoli A, Nicoloso LH, Bubols GB, Garcia SC. Development and validation of a food frequency questionnaire for consumption of polyphenol-rich foods in pregnant women. Matern Child Nutr. 2015 Oct;11(4):511-24. doi: 10.1111/mcn.12025. Epub 2013 Jan 15.</citation>
    <PMID>23316751</PMID>
  </results_reference>
  <results_reference>
    <citation>Zielinsky P, Manica JL, Piccoli AL Jr, Nicoloso LH, Barra M, Alievi MM, Vian I, Zilio A, Pizzato PE, Silva JS, Bender LP, Pizzato M, Menezes HS, Garcia SC. Fetal ductal constriction caused by maternal ingestion of green tea in late pregnancy: an experimental study. Prenat Diagn. 2012 Oct;32(10):921-6. doi: 10.1002/pd.3933. Epub 2012 Jul 23.</citation>
    <PMID>22821626</PMID>
  </results_reference>
  <results_reference>
    <citation>Bubols GB, Zielinsky P, Piccoli AL Jr, Nicoloso LH, Vian I, Moro AM, Charão MF, Brucker N, Bulcão RP, Nascimento SN, Baierle M, Alievi MM, Moresco RN, Markoski M, Garcia SC. Nitric oxide and reactive species are modulated in the polyphenol-induced ductus arteriosus constriction in pregnant sheep. Prenat Diagn. 2014 Dec;34(13):1268-76. doi: 10.1002/pd.4463. Epub 2014 Aug 22.</citation>
    <PMID>25043716</PMID>
  </results_reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2015</study_first_submitted>
  <study_first_submitted_qc>September 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2015</study_first_posted>
  <last_update_submitted>September 30, 2015</last_update_submitted>
  <last_update_submitted_qc>September 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>polyunsaturated fatty acid</keyword>
  <keyword>fetal ductus arteriosus</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

